Education
About Us
Working with TipRanks
Follow Us
CSPC Pharmaceutical Group Limited (HK:1093)
:1093
RESEARCH TOOLSreports
Total Valuation
CSPC Pharmaceutical Group has a market cap or net worth of $101.88B. The enterprise value is HK$66.79B.
Market Cap$101.88B
Enterprise ValueHK$66.79B
Share Statistics
CSPC Pharmaceutical Group has 11,518,252,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,518,252,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CSPC Pharmaceutical Group’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 11.86%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)11.86%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee1.44M
Profits Per Employee260.69K
Employee Count21,400
Asset Turnover0.65
Inventory Turnover2.78
Valuation Ratios
The current PE Ratio of CSPC Pharmaceutical Group is 12.18. CSPC Pharmaceutical Group’s PEG ratio is -0.60.
PE Ratio12.18
PS Ratio0.00
PB Ratio1.74
Price to Fair Value1.74
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio-0.60
Income Statement
In the last 12 months, CSPC Pharmaceutical Group had revenue of 30.87B and earned 4.61B in profits. Earnings per share was 0.39.
Revenue30.87B
Gross Profit21.60B
Operating Income5.71B
Pretax Income5.94B
Net Income4.61B
EBITDA6.69B
Earnings Per Share (EPS)0.39
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
CSPC Pharmaceutical Group pays an annual dividend of HK$0.1, resulting in a dividend yield of 4.42%
Dividend Per ShareHK$0.1
Dividend Yield4.42%
Payout Ratio25.34%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.95
52-Week Price Change39.54%
50-Day Moving Average6.13
200-Day Moving Average5.27
Relative Strength Index (RSI)79.12
Average Volume (3m)207.57M
Important Dates
CSPC Pharmaceutical Group upcoming earnings date is Aug 20, 2025, TBA Not Confirmed.
Last Earnings DateMay 29, 2025
Next Earnings DateAug 20, 2025
Ex-Dividend DateJun 04, 2025
Financial Position
CSPC Pharmaceutical Group as a current ratio of 2.27, with Debt / Equity ratio of 1.57%
Current Ratio2.27
Quick Ratio1.95
Debt to Market Cap<0.01
Net Debt to EBITDA-0.94
Interest Coverage Ratio0.00
Taxes
In the past 12 months, CSPC Pharmaceutical Group has paid 1.32B in taxes.
Income Tax1.32B
Effective Tax Rate0.22
Enterprise Valuation
CSPC Pharmaceutical Group EV to EBITDA ratio is 7.45, with an EV/FCF ratio of 0.00.
EV to Sales1.61
EV to EBITDA7.45
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
CSPC Pharmaceutical Group has $8.25B in cash and marketable securities with ¥507.33M in debt, giving a net cash position of -$7.74B billion.
Cash & Marketable Securities$8.25B
Total Debt¥507.33M
Net Cash-$7.74B
Net Cash Per Share-$0.67
Tangible Book Value Per Share$2.83
Margins
Gross margin is 69.97%, with operating margin of 18.50%, and net profit margin of 14.92%.
Gross Margin69.97%
Operating Margin18.50%
Pretax Margin19.23%
Net Profit Margin14.92%
EBITDA Margin21.66%
EBIT Margin18.50%
Analyst Forecast
The average price target for CSPC Pharmaceutical Group is $7.69, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$7.69
Price Target Upside-15.30% Downside
Analyst ConsensusModerate Buy
Analyst Count8
Revenue Growth Forecast-9.60%
EPS Growth Forecast-27.18%